Many glycoproteins of enveloped viruses as well as cellular proteins are covalently modified with fatty acids. Palmitoylation is often reversible, but the enzymology of this hydrophobic protein modification is not understood. Recently a cytosolic enzyme designated acyl-protein thioesterase 1 (APT1) was purified, which depalmitoylates several cellular proteins. Since hitherto no transmembrane proteins have been tested as substrates for APT1 we have investigated whether palmitoylated viral membrane glycoproteins can be deacylated by use of this enzyme. Recombinant APT1 was purified from Escherichia coli, and depalmitoylation of [ 3 H]palmitate-labeled glycoproteins present in virus particles was measured by SDS-PAGE, fluorography, and scanning densitometry. We find that APT1 causes rapid and almost complete cleavage of fatty acids from the G-protein of vesicular stomatitis virus, hemagglutinin proteins of influenza A and C virus, and E2 of Semliki Forest virus (SFV). In contrast, E1 of SFV is largely resistant against APT1 activity. This substrate specificity of APT1 was also observed using microsomes prepared from SFV-infected cells. Our data emphasize the potential of APT1 as a tool for functional analysis of protein-bound fatty acids.
INTRODUCTION
Most enveloped viruses contain at least one spike glycoprotein covalently modified with fatty acids . Well-characterized examples are the hemagglutinin (HA) of influenza virus, the Gprotein from vesicular stomatitis virus (VSV), and the E1 and E2 glycoproteins of Semliki Forest virus (SFV) (Schmidt, 1982; Schmidt and Schlesinger, 1979) . The glycoproteins are palmitoylated at conserved cysteine residues located at the border region between the transmembrane domain and the cytoplasmic (intraviral) tail (Rose et al., 1984; Veit et al., 1991) . A consensus sequence is apparently not required for palmitoylation, but specific amino acids in the transmembrane region and the cytoplasmic tail modulate the efficiency of palmitoylation (Ponimaskin and Schmidt, 1998) .
Despite numerous studies, the function of palmitoylation of viral glycoproteins is still unclear. Most researchers used recombinant DNA technology to eliminate the fatty acid-binding sites in viral glycoproteins. The resulting viruses/glycoproteins are often impaired in their biological properties such as fusion and/or budding from host cell membranes (Caballero et al., 1998; Fischer et al., 1998; Ivanova and Schlesinger, 1993; Naeve and Williams, 1990; Ryan et al., 1998; Zhang et al., 2000; Zurcher et al., 1994) . In contrast, others have found no effect with such depalmitoylated proteins (Holsinger et al., 1995; Jin et al., 1996; Naim et al., 1992; Steinhauer et al., 1991; Veit et al., 1991; Whitt and Rose, 1991) . More detailed functional studies with palmitoylated and nonacylated proteins in vitro have not been amenable because gentle methods to depalmitoylate proteins are not available. Chemical deacylation of glycoproteins with hydroxylamine can lead to unpredictable side effects causing loss of function not attributable to palmitoylation (Philipp et al., 1995) .
Though protein palmitoylation is often a reversible process with cycles of acylation and deacylation (Dunphy and Linder, 1998; Resh, 1999) , it has not been directly demonstrated for viral proteins. Enzymes involved in palmitoylation and depalmitoylation of viral as well as cellular proteins have not been identified with certainty.
Recently, progress has been reported for the study of enzymology of depalmitoylation of cellular proteins. Using palmitoylated ␣-subunits of heterotrimeric G-proteins as substrate, an enzyme with depalmitoylating activity was purified from rat liver and designated acyl-protein thioesterase 1 (APT1) (Duncan and Gilman, 1998) . Endothelial nitric oxide synthetase (e-NOS) is also a substrate for this enzyme (Yeh et al., 1999) . Peptide sequencing of APT1 revealed that it is identical to rat lysophospholipase, an enzyme purified previously by others (Sugi-moto et al., 1996) . APT1 also hydrolyzes palmitoyl-coenzyme A (Pal-CoA), the lipid substrate for palmitoylation. Although APT1 is multifunctional, experimental comparison of its K m values for the acyl cleavage in G␣s, Lyso-PC, and Pal-CoA revealed that acylproteins are the preferred substrate, at least in vitro (Duncan and Gilman, 1998) . The crystal structure of APT1 was published recently, providing insights into the catalytic mechanism of the enzyme (Devedjiev et al., 2000) .
APT1/lysophospholipase is a cytosolic protein with a molecular mass of 25 kDa. It is expressed in every mammalian cell type examined and homologues have been identified in lower organisms such as Saccharomyces cerevisiae and Caenorhabditis elegans (Duncan and Gilman, 1998; Sugimoto et al., 1996) . Here we show for the first time that recombinant APT1 purified from Escherichia coli can release fatty acids from palmitoylated viral glycoproteins indicating that this enzyme operates also on typical transmembrane proteins. Mancini et al. (2000) ). This is consistent with the identification of four versus only one palmitoylation site(s) in E2 and E1, respectively (Ivanova and Schlesinger, 1993; Schmidt et al., 1988) .
RESULTS AND DISCUSSION
To test whether E1 and E2 are substrates for APT1, recombinant 6xHis-APT1 was purified from E. coli (see Fig. 1A ) and incubated at various concentrations (0.01 to 10 g) with SFV particles (120 g) in the presence of Triton X-100. The assay was stopped after 30 min with nonreducing SDS-PAGE buffer and samples were subjected to electrophoresis followed by Coomassie staining (Fig. 1B) . The fluorogram of the stained gel revealed that the APT1 cleaves the fatty acids from the E2 glycoprotein in a concentration-dependent manner (Fig. 1C) . One microgram of APT1 present in the assay was sufficient for an almost quantitative cleavage. In contrast, almost 80% of the fatty acids bound to the E1 glycoprotein remain stably attached even after treatment with 10 g of APT1.
Cleavage of fatty acids from E2 was successfully abolished by either boiling of APT1 prior to the assay (data not shown) or substituting the denaturing detergent SDS (0.2%) for Triton X-100 (Fig. 1C , sample designated 10 SDS ). This underscores the enzymatic nature of the reaction, as the cleavage of fatty acids from viral spikes requires the presence of a nondenaturing detergent like Triton X-100. Virus particles incubated with APT1 in the absence of Triton failed to show fatty acid cleavage (see Fig. 3 , top, lane designated 40 Ϫ ). When whole virus particles were used as protein substrate, Triton X-100 was required to solubilize the viral membrane and make the intraviral fatty acid-binding sites accessible to APT1.
We tested this assumption with substrate proteins in which the fatty acid-binding sites are accessible to APT1 in the absence of detergent, i.e., SFV glycoproteins present in microsomes of virus-infected cells. BHK cells infected with SFV were labeled overnight with [ 3 H]palmitate, and microsomes were prepared and incubated with APT1. The resulting fluorogram revealed significant cleavage (ϳ60%) of fatty acids from E2, but not from E1 (see Fig. 2 ). Thus, it is observed that the activity of APT1 does not require detergent and the preference of APT1 for E2 is preserved under those conditions. Microsomes were also incubated in the presence of Triton X-100 with APT-1, which resulted in a complete cleavage of fatty 3 H]Palmitate-labeled Semliki Forest virus (120 g total protein) was incubated with 1% Triton X-100 and increasing amounts of APT1 (0.01 to 10 g) for 30 min at 30°C. Samples were then subjected to SDS-PAGE under nonreducing conditions followed by Coomassie staining (B) and fluorography (C). One sample contained SDS (0.2%) instead of Triton. The two glycoproteins of SFV and the nonpalmitoylated capsid protein are designated E1, E2, and C, respectively. Coomassie-stained bands marked with an asterisk are probably due to the formation of intramolecular disulfide bonds after cleavage of fatty acids from E2 (see Results) .
(D) [
3 H]Palmitate-labeled Semliki Forest virus was incubated with 10 g APT1 in the presence of 1% Triton X-100 and increasing concentrations of calcium chloride or magnesium chloride for 30 min at 30°C. Samples were then subjected to SDS-PAGE and fluorography with a 5-day exposure.
acids from E2 (data not shown). However, the detergent requirement of APT1 cannot be determined exactly with this assay because Triton X-100 might also unveil additional palmitoylation sites that otherwise are buried in the bilayer or masked by interactions with other proteins.
It has been described that calcium at millimolar concentrations potentiates depalmitoylation of endothelial nitric oxide synthase (e-NOS; Yeh et al., 1999) , whereas no effect of calcium was detectable on depalmitoylation of ␣-subunits of heterotrimeric G-proteins (Duncan and Gilman, 1998 ). Therefore we tested the effect of calcium and another divalent cation (magnesium) on depalmitoylation of E1 and E2 of Semliki Forest virus. We found no divalent cation requirement for deacylation of viral glycoproteins (see Fig. 1D ). In contrast at nonphysiological concentrations (10 mM) divalent cations inhibited fatty acid cleavage from the E2 glycoprotein and also the deacylation of G-protein of VSV and of HEF protein of influenza C virus (see Fig. 4 ). Therefore it seems unlikely that calcium stimulates the thioesterase activity of APT1 in general as suggested by the initial data with e-NOS, but rather its effect depends on the acylprotein under investigation.
To compare the efficiency of enzymatic deacylation of the two structural proteins E1 and E2, SFV was incubated with 10 g of APT1 for different periods of time (1 to 40 min) and the resulting fluorograms were quantified by scanning densitometry. As apparent from Fig. 3 , a 5-min incubation resulted in the cleavage of more than 60% of fatty acids from E2 and after 20 min the reaction reached saturation with more than 90% cleavage of E2-bound fatty acids. In contrast, cleavage of fatty acids from E1 is quite slow. It was barely detectable after 5 min and only 25% of E1-linked fatty acids were cleaved after 40 min of incubation time. The results presented in Figs. 1 to 3 provide conclusive evidence that APT1 works with different efficiencies on E1 and E2 of Semliki Forest virus. Similar results were obtained for E1 and E2 glycoproteins of the closely related Sindbis virus (data not shown).
The kinetics of fatty acid cleavage from E2 were similar to those reported for the ␣-subunits of hetereotrimeric G-proteins and for the ras protein. However, only 50% of covalently linked fatty acids were cleaved from both cellular proteins (Duncan and Gilman, 1998) .
It was surprising to find that relatively large amounts (1 g) of APT1 were required to obtain cleavage of proteinbound fatty acids. Our calculations showed the enzyme: substrate ratio for this reaction to be about 1:80 and published data on enzyme:substrate ratios with cellular acylproteins and recombinant APT1 revealed comparable values. The native enzyme purified from rat liver has a slightly lower enzyme:substrate ratio (Duncan and Gilman, 1998) . 
Deacylation by APT1 of other viral membrane proteins
We have reported recently that E1 and E2 are acylated with different fatty acid species. It was found that E2 contained mainly palmitic acid, and E1 acylated predominantly with stearic acid (Veit et al., 1996) . Thus, with the results shown in Figs. 1 to 3 , it may be conceived that APT1 has a preference for palmitate as protein-bound fatty acid over longer acyl chains. Therefore we investigated whether APT1 cleaves fatty acids from the HEF glycoprotein of influenza C virus, another glycoprotein acylated predominantly with stearic acid (Veit et al., 1990 (Veit et al., , 1996 . In contrast to E1, HEF proved to be a good substrate for APT1 (see Fig. 4, left) . Complete cleavage of fatty acids was obtained with 10 g of APT1 and approximately 65% cleavage was detectable with 1 g of the enzyme. However, the possibility cannot be excluded that the 3 H-labeled fatty acid content of viral glycoproteins varies from preparation to preparation, possibly due to varying metabolism of externally added [ 3 H]palmitate. Therefore we analyzed the 3 H-labeled fatty acid content of E1 and E2 of SFV and of HEF of influenza C virus from the same virus preparations that were used in the deacylation experiments with APT1. [ 3 H]Palmitatelabeled glycoproteins were purified by SDS-PAGE and cut from the gel, and fatty acids were liberated with 6 N HCl and extracted with hexane. Thin-layer chromatography revealed that both E1 and HEF contain almost ex-
clusively [
3 H]stearic acid, whereas E2 is acylated mainly with [ 3 H]palmitic acid (see Fig. 5 ). Thus, it is unlikely that the inefficient cleavage of fatty acid from E1 of SFV is due to its predominant acylation with stearic acid.
In extending our study of APT1 action on other wellcharacterized viral glycoproteins, we found that both the
FIG. 4. Depalmitoylation of HEF protein of influenza C virus and of G-protein of VSV. 100 g of total protein, from [
3 H]palmitate-labeled influenza C virus (left) and vesicular stomatitis virus (VSV, right), was incubated with increasing amounts of APT1 in the absence (10 Ϫ ) or presence of Triton X-100 (1% final concentration) for 30 min at 30°C. One sample also contained calcium chloride (10 mM, 10 ϩCa ). Samples were then subjected to SDS-PAGE under nonreducing conditions with subsequent Coomassie staining (A) and fluorography (B). Viral proteins are designated as follows: HEF and G are the membrane glycoproteins and NP and N are the nucleocapsid proteins of influenza C virus and VSV, respectively. (C) Coomassie-stained bands representing the suspected G-protein dimer (lanes 1 and 2) and monomer (lane 3) in A were excised and subjected to SDS-PAGE under reducing conditions.
FIG. 5. Fatty acid analysis of viral glycoproteins. Glycoproteins from [
3 H]palmitate-labeled SFV and Flu C preparations were purified by SDS-PAGE, and protein-bound fatty acids were liberated with 6 N HCl, extracted with hexane, and subjected to TLC analysis and fluorography. Identity of bands was confirmed with radioactive reference substances run on the same TLC plate. E1 and E2 are the glycoproteins from SFV; HEF is the glycoprotein from Flu C. The band marked with an asterisk is material trapped between the concentration and the separation zones of the TLC plate.
G-protein of vesicular stomatitis virus (Fig. 4, right) and the hemagglutinin (HA) of influenza A virus (strains virus N and fowl-plaque virus; data not shown) act as substrates for this deacylating enzyme. Complete cleavage of fatty acids from 150 g of VSV particles was obtained with 1 g of APT1.
Close inspection of Coomassie-stained gels after PAGE separation of influenza C virus and VSV proteins revealed the appearance of an additional band of high molecular weight in the APT1-treated samples (bands designated Dimer in Fig. 4A ). The intensity of Coomassie staining of the authentic bands of G and HEF protein monomers decreased simultaneously with the appearance of this new suspected dimer band. Thus, it is likely that with both influenza C and VSV proteins, the highmolecular-weight material consists of disulfide-linked oligomers of HEF and G, respectively, which persist during electrophoresis under nonreducing conditions. The disulfide bonds yielding dimers are formed only when free cysteine residues become available after fatty acid cleavage. In order to prove this assumption, the high-molecular-weight bands (marked 1 and 2 in Fig. 4 ) and the G-protein band (marked 3) were excised from the gel and subjected to electrophoresis under reducing conditions. As expected, both the new high-molecularweight band and the authentic G-protein run to the same position after the disulfide bonds are reduced (see Fig.  4C ). Bands corresponding to oligomers of E2 were not observed with APT1-treated Semliki Forest virus preparations. Instead, there is a slight reduction in the electrophoretic mobility of this protein (see Fig. 1 , bands marked with an asterisk). E2 contains four palmitoylation sites and therefore it is likely that intramolecular instead of intermolecular disulfide bonds are formed after fatty acid cleavage, which makes the protein run faster.
Our data show that most acylated viral glycoproteins are good substrates for APT1 in vitro. Almost complete cleavage of fatty acids was obtained with E2 of Semliki Forest virus, HA and HEF of influenza viruses, and the G-protein of vesicular stomatitis virus. Using these membrane proteins as substrate, the enzyme:substrate ratio to obtain cleavage was relatively high, but on the same order of magnitude as published results with cellular acylproteins and lower than that for the Pal-CoA hydrolase activity of APT1. In contrast to all other viral acylproteins tested, E1 of SFV is apparently a poor substrate for APT1. This indicates that APT1 does not work on every palmitoylated protein with the same efficiency.
It is well established that palmitoylation of several cellular acylproteins is reversible with cycles of acylation and deacylation (Resh, 1999) . In contrast, cleavage of fatty acids was not observed for viral glycoproteins in transit from the endoplasmic reticulum to the plasma membrane and purified viral glycoproteins contain fatty acids in stoichiometric amounts (Schmidt and Schlesinger, 1979; Veit and Schmidt, 1993) . It is therefore unlikely that APT1 is active on viral glycoproteins in virusinfected cells. We have found that the fatty acid-binding sites of E2, present in microsomes prepared from SFVinfected cells, are accessible to APT1. Thus the question arises as to why viral glycoproteins are good substrates for APT1 in vitro (even better than the cellular acylproteins tested so far), but apparently not in vivo. An apparent possibility would be that APT1 and viral glycoproteins localize to different cellular compartments. However, APT1 was purified from the cytosol and therefore it should have access to the palmitoylation sites located in the cytoplasmic tail of viral glycoproteins. One possible explanation would be that the fatty acids are protected by association of the cytoplasmic tail with other viral membrane proteins, e.g., with the matrix protein in the case of influenza viruses and with the capsid protein for SFV.
Clearly, the function of APT1 in vivo, its substrates, and its regulation need to be more precisely defined. However, despite the present lack of evidence for a physiological role of APT1 for viral glycoproteins, the enzyme could prove to be a potent tool for gentle depalmitoylation of proteins in vitro. Replacing the method of chemical deacylation with hydroxylamine by use of enzymatic deacylation of proteins with APT1 may stimulate progress in future studies of the biological functions of protein-linked fatty acids. With APT1 operating on viral membrane proteins it may also prove useful for functional studies of the many palmitoylated membrane receptors.
MATERIALS AND METHODS

Buffers
TN buffer consists of 20 mM Tris/HCl; 150 mM NaCl at pH 7.4; wash buffer consists of TN with 10 mM imidazol; elution buffer was TN with 100 mM imidazol; sonication buffer was TN with 1 mM PMSF. TNE buffer contains 20 mM Tris/HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA. SDS-PAGE sample buffer (nonreducing, final concentration) contains 62.5 mM Tris/HCl, pH 6.8, 2% SDS, 10% glycerol. The reducing sample buffer contains 5% ␤-mercaptoethanol.
Purification of recombinant APT1 from E. coli XL-1 blue E. coli cells transformed with pQE60 plasmid (Qiagen, Hilden, Germany) containing the APT1 gene (Duncan and Gilman, 1998) were grown in medium containing ampicillin (50 g/ml) to an optical density of 0.6. IPTG (final concentration of 1 mM) was added and the cells were grown for an additional 16 h at 37°C. Cells were pelleted (10 min at 5000g) and frozen at Ϫ80°C or processed immediately.
All subsequent steps were performed on ice or at 4°C. E. coli cell pellets were resuspended in sonication buffer (5 ml per 100 ml of bacterial culture medium) and cells were broken by sonication with an ultrasonic cell dis-rupter (three bursts at 5-W setting). Lysozyme (1 mg/ml) and DNase I (2 g/ml) were added and samples were incubated for 30 min prior to an additional sonication step. Triton X-100 was added to a final concentration of 0.5% and the solution was stirred for 20 min. Following another sonication step, cell debris was pelleted (20 min at 10,000g) and discarded. The supernatant was incubated for 1 h with Ni-NTA-agarose (Qiagen), with 100 l of a 50% slurry used per 500 l of supernatant. Agarose with bound proteins was transferred to a column that was subsequently washed three times with wash buffer. Proteins were eluted with elution buffer, dialyzed against TN buffer, and stored at Ϫ80°C for further studies. Protein concentration was determined with the DC protein assay kit II from Bio-Rad (Munich, Germany), which is based on the Lowry method. This procedure yields 0.5 to 2.5 g of protein per milliliter of culture medium. Purity of proteins was Ͼ95% as analyzed by SDS-PAGE and Coomassie blue staining (see Fig. 1A ).
Growth, labeling, and preparation of virus particles
All procedures applied have been described before (Schmidt, 1982; Schmidt and Schlesinger, 1979; Veit et al., 1990) . Briefly, VSV and SFV were grown in BHK cells and influenza viruses were grown in MDCK II cells (influenza A strains: fowl plaque virus (H7) and Virus N (H10)) or MDCK I cells (influenza C virus). Infected cells were labeled 3 h postinfection with [ 3 H]palmitic acid. Viruses were pelleted from the cell culture fluid 16 or 48 h (influenza C) after infection. Virus particles were resuspended in TN buffer and stored at Ϫ80°C until further use. The protein concentration was determined with the DC protein assay kit II from Bio-Rad.
Preparation of [
3 H]palmitate-labeled microsomes from SFV-infected cells BHK cells were infected with SFV at 37°C as described above and labeled with [ 3 H]palmitate (100 Ci/ml medium) at 3 h postinfection for 14 h. Labeling was done at 30°C to retard virus growth. Infected cells were then scraped, pelleted (2000g for 10 min), washed with PBS, pelleted again, and resuspended in hypotonic buffer (20 mM HEPES-NaOH, pH 7.4, 50 mM NaCl, 1 mM EDTA, 1 mM PMSF; 1 mg/ml leupeptin, 1 mM pepstatin). Cells were broken with 40 strokes in a tight-fitting douncer. Unbroken cells and large membrane fragments were pelleted (2000g for 10 min) and the resulting supernatant was subjected to ultracentrifugation (100,000g for 1 h). The resulting microsomal pellet was resuspended in TN buffer and stored at Ϫ80°C.
Depalmitoylation assay with virus particles and microsomes from virus-infected cells
In the standard assay 5 to 10 l of [ 3 H]palmitatelabeled virus particles (100-300 g total protein) was incubated with 10 g of APT1. TN buffer was added to a final volume of 40 l. Assays also contained Triton X-100 at a final concentration of 1% if not stated otherwise. Samples were incubated at 30°C for 30 min. Any deviations from this standard assay are indicated in the figure legends. Microsomes (200 g) from SFV-infected cells were incubated with 10 g of APT1 in a final volume of 40 l TN buffer in the absence of Triton X-100 at 30°C for 1 h. Reactions were stopped by adding 20 l of 3ϫ concentrated nonreducing SDS-PAGE sample buffer.
Analysis of protein-bound fatty acids
Analysis of protein-bound fatty acids was conducted as described (Veit et al., 1990) . Briefly, glycoproteins from [ 3 H]palmitate-labeled virus preparations were purified by SDS-PAGE and cut from the gel. The dried gel pieces were incubated with 6 N HCl for 16 h at 110°C in tightly sealed ampules. Liberated fatty acids were extracted three times with hexane, pooled, and concentrated in a stream of nitrogen. Separation into individual fatty acid species was done on RP-18 HPTLC plates (Merck, Mannheim, Germany) with acetonitrile:acetic acid (1:1) as solvent system. Radioactivity on the thin-layer plate was made visible by spraying with En 3 Hance (Amersham).
SDS-PAGE, fluorography, and quantification
Samples were separated by PAGE using 12% SDS gels under nonreducing conditions. Gels were stained with Coomassie, destained with 10% ethanol and 10% acetic acid, washed with distilled water (30 min), and treated with 1 M sodium salicylate (30 min). The gels were then dried and exposed to X-ray film. Film exposure times were between 2 and 10 days. For densitometric quantitation of bands on X-ray films with different exposure times, we used an Epson scanner GT 9000 and ScanPack 3.0 software (Biometra, Göttingen, Germany).
